Monitoring Agency Report for the quarter and year ended March 31, 2025
VAKRANGEE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
CARE Ratings, as Monitoring Agency, has filed its report on the use of proceeds from Vakrangee's Rs. 162 crore preferential issue (6 crore convertible warrants at Rs. 27 each). Out of Rs. 162 crore planned, only Rs. 88.94 crore was actually raised till March 31, 2025, with Rs. 73.06 crore yet to be received from warrant holders. Of the Rs. 88.94 crore raised, Rs. 88.84 crore has been utilized — mainly Rs. 50.64 crore for loan repayment, Rs. 32.19 crore for strategic investments, Rs. 5.01 crore for general corporate purposes, and Rs. 1 crore for business expansion. No deviation from the stated objects was reported, but the agency flagged that delayed receipt of the remaining subscription could affect project viability. The company also disclosed that promoter and Chairman Emeritus Mr. Dinesh Nandwana passed away on January 31, 2025, and that the share price has fallen nearly 60% since the preferential issue was announced in February 2024.
Mixed-to-negative for shareholders: while the company has used the funds as planned, only about 55% of the targeted Rs. 162 crore has been raised, the stock has dropped sharply (~60%), and key leadership changes (promoter's demise and CEO exit) add uncertainty. Investors should watch for completion of the remaining warrant conversions and any further impact on share price.